NGM BIOPHARMACEUTICALS INC

CUSIP: 62921N105 Class: Common Stock

GOLDMAN SACHS GROUP INC's Holding History (CIK: 0000886982)

Note: Option positions (PUT/CALL) are excluded.

Q1 2024
Shares 209,298 Value ($000) $333 Avg Close — Range —
Q4 2023
Shares 110,682 Value ($000) $95 Avg Close — Range —
Q3 2023
Shares 273,361 Value ($000) $292 Avg Close — Range —
Q2 2023
Shares 236,736 Value ($000) $613 Avg Close — Range —
Q1 2023
Shares 190,803 Value ($000) $778 Avg Close — Range —
Q4 2022
Shares 379,658 Value ($000) $1,906 Avg Close — Range —
Q3 2022
Shares 333,639 Value ($000) $4 Avg Close — Range —
Q2 2022
Shares 172,206 Value ($000) $2 Avg Close — Range —
Q1 2022
Shares 163,918 Value ($000) $2,500 Avg Close — Range —
Q4 2021
Shares 206,814 Value ($000) $3,663 Avg Close — Range —
Q3 2021
Shares 251,485 Value ($000) $5,286 Avg Close — Range —
Q2 2021
Shares 57,823 Value ($000) $1,140 Avg Close — Range —
Q1 2021
Shares 51,381 Value ($000) $1,494 Avg Close — Range —
Q4 2020
Shares 48,025 Value ($000) $1,454 Avg Close — Range —
Q3 2020
Shares 53,122 Value ($000) $845 Avg Close — Range —
Q2 2020
Shares 60,396 Value ($000) $1,193 Avg Close — Range —
Q1 2020
Shares 44,533 Value ($000) $549 Avg Close — Range —
Q4 2019
Shares 86,519 Value ($000) $1,600 Avg Close — Range —
Q3 2019
Shares 54,512 Value ($000) $755 Avg Close — Range —
Q2 2019
Shares 56,203 Value ($000) $823 Avg Close — Range —